Skip to main navigation Skip to search Skip to main content

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin-naive patients with extensive-disease small cell lung cancer (Cancer (2009) 116, (132-136))

  • D. H. Lee
  • , S. W. Kim
  • , C. Suh
  • , J. S. Lee
  • , J. S. Ahn
  • , M. J. Ahn
  • , K. Park
  • , I. I. Na
  • , J. C. Lee
  • , B. Y. Ryoo
  • , S. H. Yang
  • University of Ulsan

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)540
Number of pages1
JournalCancer
Volume116
Issue number2
DOIs
StatePublished - 15 Jan 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this